click here to read full article
Read More
Author: jb
Stablepharma enters Phase 1 Clinical Trials with world-first Fridge-Free Td Vaccine
Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial led by Professor Saul Faust, is being conducted at the National Institute for Health and Care Research (NIHR) at Southampton Clinical Research Facility. Stablepharma’s pioneering science has […]
Read More
Stablepharma & AJ Vaccines sign strategic LoI to distribute and commercialise Fridge-free Vaccines
click here to read full article
Read More
Stablepharma welcomes Sir Jonathan Van-Tam to its advisory board
Fridge-free vaccines could greatly expand access worldwide – University Hospital Southampton (UHS)
Researchers at University Hospital Southampton (UHS) are working with Stablepharma Ltd to trial vaccines that don’t need to be kept cold. The partners have been awarded a joint grant by Innovate UK to develop a fridge-free vaccine, SPVX02, to prevent tetanus and diphtheria.
Read More